235 related articles for article (PubMed ID: 24121274)
1. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.
Tsai CH; Teng CH; Tu YT; Cheng TS; Wu SR; Ko CJ; Shyu HY; Lan SW; Huang HP; Tzeng SF; Johnson MD; Lin CY; Hsiao PW; Lee MS
Oncogene; 2014 Sep; 33(38):4643-52. PubMed ID: 24121274
[TBL] [Abstract][Full Text] [Related]
2. The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer Cells.
Wu SR; Teng CH; Tu YT; Ko CJ; Cheng TS; Lan SW; Lin HY; Lin HH; Tu HF; Hsiao PW; Huang HP; Chen CH; Lee MS
Sci Rep; 2017 Nov; 7(1):15101. PubMed ID: 29118397
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
[TBL] [Abstract][Full Text] [Related]
5. Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness.
Baba T; Kawaguchi M; Fukushima T; Sato Y; Orikawa H; Yorita K; Tanaka H; Lin CY; Sakoda S; Kataoka H
J Pathol; 2012 Oct; 228(2):181-92. PubMed ID: 22262311
[TBL] [Abstract][Full Text] [Related]
6. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L; Cao J; Zhang X
World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
[TBL] [Abstract][Full Text] [Related]
7. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
Warren M; Twohig M; Pier T; Eickhoff J; Lin CY; Jarrard D; Huang W
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):23-30. PubMed ID: 18813126
[TBL] [Abstract][Full Text] [Related]
8. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
11. Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.
Kanemaru A; Yamamoto K; Kawaguchi M; Fukushima T; Lin CY; Johnson MD; Camerer E; Kataoka H
Int J Cancer; 2017 Jan; 140(1):130-141. PubMed ID: 27615543
[TBL] [Abstract][Full Text] [Related]
12. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation.
Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG
J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907
[TBL] [Abstract][Full Text] [Related]
13. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.
Wu SR; Cheng TS; Chen WC; Shyu HY; Ko CJ; Huang HP; Teng CH; Lin CH; Johnson MD; Lin CY; Lee MS
Am J Pathol; 2010 Dec; 177(6):3145-58. PubMed ID: 20971737
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
15. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
16. Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2.
Chiu YL; Wu YY; Barndt RB; Yeo YH; Lin YW; Sytwo HP; Liu HC; Xu Y; Jia B; Wang JK; Johnson MD; Lin CY
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):692-702. PubMed ID: 30777474
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
18. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
[TBL] [Abstract][Full Text] [Related]
19. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells.
Kiyomiya K; Lee MS; Tseng IC; Zuo H; Barndt RJ; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C40-9. PubMed ID: 16467405
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TMPRSS2 by HAI-2 reduces prostate cancer cell invasion and metastasis.
Ko CJ; Hsu TW; Wu SR; Lan SW; Hsiao TF; Lin HY; Lin HH; Tu HF; Lee CF; Huang CC; Chen MM; Hsiao PW; Huang HP; Lee MS
Oncogene; 2020 Sep; 39(37):5950-5963. PubMed ID: 32778768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
